WO2010053463A1 - Surface disinfection device - Google Patents
Surface disinfection device Download PDFInfo
- Publication number
- WO2010053463A1 WO2010053463A1 PCT/TR2009/000134 TR2009000134W WO2010053463A1 WO 2010053463 A1 WO2010053463 A1 WO 2010053463A1 TR 2009000134 W TR2009000134 W TR 2009000134W WO 2010053463 A1 WO2010053463 A1 WO 2010053463A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- duct
- ventouse
- peripheral
- drug
- tent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
Definitions
- This invention is used in the application of drugs used for the diagnosis and treatment of the infections of easy accessible areas such as skin ( burnt skin, infected skin, preoperation antisepsis of skin ), gingiva, buccal mucosa, tongue, lips, nasopharynx, oropharynx, nasal and vaginal mucosa, the front zone of the eye globe and the precancerous and cancerous lesions (local chemotherapeutics, radiosensitizers, photosensitizers, cryogenic agents, chemosurgery agents, substances such as the ionized argon used in the argon plasma technique, liquids used for the thermochemotherapy and thermochemosurgery, liquid local hemostatics, antimicrobial drugs for treating the persistence infections, antimycotic drugs, some drugs and dyes used for the diagnosis and, liquid, gas or pomade substances that will accelerate the tissue healing).
- skin burnt skin, infected skin, preoperation antisepsis of skin
- gingiva buccal muco
- Window cleaning can be done by water, detergent, moist hot air sent for cleaning and hot dry air sent fro drying into the tent room ( 1 ) of devices with the ventouse edges suitable for the peripheral shapes of windows.
- Pomades are relatively effectively used only for the skin and, the liquid drugs are used in a staining way.
- mobility of the saliva and tissues inhibits the drug to stay in the application area for a long time.
- the photosensitizers used for the cancer treatment are administered systemically and require 1-5 days to become effective in the body (delay in the treatment) and, their photosensitizing adverse effects for the patients lasts for weeks.
- the patients exposed to the light can have critical problems.
- thermochemotherapy and thermochemotherapy agents cannot be applied, since the liquid spread cannot be limited to single area because of the heat.
- the leucoplasias and some oral lichen planus are considered as the precancerous lesions by some specialists and nonselective cryotherapies are performed.
- Ring ventouse system is used for fixing the eyeball in the eye surgery (Hessburg- Barron Vacuum Trephine).
- Hessburg- Barron Vacuum Trephine Hessburg- Barron Vacuum Trephine
- the Surface Disinfection Device the upper part of peripheral ventouse, including the area in the center of ventouse ( 6 ), is covered by an elastic membrane. Thus, a closed tent room ( 1 ) is formed.
- a Surface Disinfection Device When a Surface Disinfection Device is placed on a tissue ( 3 ) and the air in the peripheral ventouse ( 2 ) is vacuumed, the device firmly adheres to the lower tissues and does not drain the drugs and chemical substances sent into the tent via the disinfection duct ( 20 ), unless it is desired.
- the invention named medicinal component delivery system moves the skin upward-downward significantly in the medicine application zone with the discharge pump and ultrasonic module. This causes burnt skin, infected skin and an unacceptable case for medicine application on the front zone of the eye globe. Our device does not apply positive or negative pressure on and does not disturb the medicine application zone in any manner.
- the medicine application zone is only the sub-part of the structure #31. In our device, the medicine application zone is the entire surface in the inner tent area ( 3 ).
- Such kind of an ultrasonic module is not required to apply many medicines.
- This module increase the price and weight of the system. As the weight increases, it will be required to increase the negative pressure needed to keep the system attached to the tissue, which means edema, hemorrhage and hematome on the tissue.
- the cleaning is done directly by hand by the people on the structures suspended from top of the building.
- the device ensures that the desired drug concentration is attained and maintained in the desired area. This ensures an increase in the success of
- the device allows very little amounts of drug to pass to the systemic circulation by passing through the skin and mucosa in the application area.
- the radiosensitizers that areally applied become effective further and in a shorter time.
- the administered drug can be kept in the area as long as desired. This means that the drug efficiency will continue as long as desired. For example, some microorganisms should be kept under influence by the antimicrobial drugs for dying. This is ensured in the systemic applications by frequently, long
- the area may be deoxidized in order to kill the aerobes.
- the air in the tent room ( 1 ) is vacuumed and instead, substances in the aerosol form that will kill the microorganisms and will not harm the underlying tissue can be given.
- the microorganisms can be killed by making the pH of area
- the detergent does not become disposable after the cleaning of one window, the remaining detergent can be retrieved from the disinfection duct ( 20 ) and used in the cleaning of next window.
- the peripheral ventouse ( 2 ) is designed as factory made in various geometric figures and various diameters according to the application area.
- the peripheral ventouse system is U-shaped and able, to grasp the lips.
- the outer edges of those that will be used in the buccal mucosa should be appropriate for the area's anatomy. It should be designed in different circumferential lengths according to the age. Again, it should be designed as 160 factory made in different dimensions by considering that some people may have bigger or smaller mouths.
- thermochemotherapy In the applications of thermochemotherapy and thermochemosurgery, whole system is made of heat resistant materials.
- peripheral ventouse ( 5 ) should be as short as possible. Thus, the required amount of drug decreases and then, the cost and negative pressure that is enough to overcome the severity of drug are also reduced. The height of
- peripheral ventouse ( 5 ) should be high enough not to cause the tent part will touch the application surface. Non-touching of tent surface to the application surface should not be ensured by drug administering with pressure. Otherwise, it will be required to create more negative pressure within the peripheral ventouse system ( 2 ) in order to overcome such pressure.
- peripheral ventouse 's lips ( 7 ) adhering to the tissue shall be elastic so as not to irritate the tissue and so as can adapt to the surrounding anatomic structure.
- peripheral ventouse system's width ( 15 ) should be preferred.
- Whole system shall be made of elastic and transparent materials that will not be affected by the chemical substances to be used in the application and harm the structure of such substances. Its edge's form should match up with the form of window's edge.
- Tent room ( 1 ) It is the application area of the drug of which upper part is surrounded by an elastic membrane forming the ceiling ( 6 ) of tent room, lower part is surrounded by the tissue and edges are surrounded by the inner wall ( 14 ) of ventouse.
- Peripheral ventouse ( 2 ) Vacuuming in this area sticks the Surface 195 Disinfection Device to the tissue. As a result of this adherence, the drugs administered to the tent room cannot leak out.
- Application area ( 3 ) Floor section of the tent room.
- Figure 1 ) d.
- Outlet of air bleed duct ( 9 ) It is located on the outer edge of ducts system ( 16 ).
- Outlet of disinfection duct ( 10 ) It is located on the outer edge of ducts system ( 16 ) .
- Inlet of air bleed duct ( 12 ) It is located in the middle, on the
- Inlet of vacuum duct ( 13 ) It is in the middle of ceiling ( 15 ) of peripheral ventouse ( 2 ). It is the inlet port of vacuum duct ( 17 ) (
- Vacuuming can be performed from 1, 2, 3 or 4 points according to the size of ventouse system.
- Inner wall of peripheral ventouse ( 14 ) It is the inner wall ( 14 ) of
- peripheral ventouse ( 2 ) The device ends here( 21 ) in the devices with an observation instrument in an area of this wall close to the tent( 6 ), in the inner part fronting on the tent room( 1 ). Again, there is the inlet of disinfection duct ( 22 ) in the part of this wall close to the ground.
- Vacuum Duct ( 17 ) It is the duct vacuuming the air in the peripheral ventouse ( 2 ) ( Figure 6 ). It is located within the ducts system ( 4 ). 260 Vacuuming can be performed from 1, 2, 3 or 4 points according to the size of ventouse system. In this case, the branches from the vacuum duct or additional vacuum ducts are constituted. r. Air bleed duct ( 18 ) : It is the duct that ensures the air in the tent room to be bled to the external environment. Thus, inside of the room 265 is filled with the drug. It prevents the positive pressure generation in the tent room ( 1 ) during the drug administering. This duct also ensures that the drug is activated by aerating the drug, where the drug in the tent room ( 1 ) is desired to be activated from time to time.
- Disinfection duct ( 20 ) It is the duct that carries the drug from outside to underneath of the tent during the drug administering and from inside of the tent to outside during the drainage. It is located 275 within the ducts system ( 4 ).
- t. Observation instrument duct ( 19 ) It includes the systems for observing the tent room ( 1 ). It is located within the ducts system
- FIG. 4 ( Figure 4 ) u. Inlet of Disinfection duct ( 22 ) : It is the outlet port of drug 280 administering and drainage duct opening into the tent room (1). It is on the side of inner cylinder ( 14 ) constituting the peripheral ventouse, fronting on the tent room ( 1 ) and in an area of tent close to the application area ( 3 ). ( Figure 5 ) v. Beginning of observation system ( 21 ) : It is located over the inner 285 . wall ( 14 ) of peripheral ventouse and in an area close to the tent ( 6 ).
- the fiber optic systems that can observe the application area can be located close to the upper part of ventouse' s wall fronting on the tent area or in the middle of tent. ( Figure 4 )
- the device of which shape is optimal for the area of lesion is selected. If the drug is a hot liquid, the physical structure of device should be suitable for that. If the drug is likely to be affected by light, a device that is light-proof is used or, during the drug administering, the tent is covered by a light-proof cloth.
- a device that will match up with the surface of window is selected. It is made of transparent materials. Since the ventouse edges will constitute the frame, they are made of thicker elastic materials such as the rigid plastic. Application in Medicine
- the patient Before administering the drug, the patient is located so as that the drug will reach the target tissue in an easiest way according to the gravity. This will be different for the liquids and gases.
- the Surface Disinfection Device is located in the lesion area. While it is kept in a condition slightly pressed through a finger or a tool, the vacuum
- a negative pressure is generated in the peripheral ventouse area.
- the tent room ( 1 ) is not fully filled where the liquid drug is required to be activated from time to time by aerating.
- a full drainage is achieved by inserting a vacuum device 330 to the inlet of disinfection duct ( 11 ).
- the negative pressure in the peripheral ventouse ( 2 ) is relieved by opening the outlet of vacuum duct ( 8 ).
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Prevention Of Fouling (AREA)
Abstract
The Surface Disinfection Device keeps the drugs, chemical substances and gases sent to the tent room ( 1 ) through the disinfection duct ( 20 ) in the application area for a desired time and in a desired concentration by vacuuming the air in its peripheral ventouse ( 2 ) and confining such drugs and substances in the closed tent room ( 1 ) constituted by means of the ceiling ( 6 ) of tent room. It does not leak out of the tent room. The adverse or unnecessary effects of the drugs that cannot go out of the closed system are prevented for the other tissues. The Surface Disinfection Device is used for the cleaning and drying of high buildings' windows without scattering the liquid detergents sent to the tent room( 1 ) around.
Description
SURFACE DISINFECTION DEVICE
Related Technical Field of Invention
Its usage in the medicine for the purpose of surface disinfection;
This invention is used in the application of drugs used for the diagnosis and treatment of the infections of easy accessible areas such as skin ( burnt skin, infected skin, preoperation antisepsis of skin ), gingiva, buccal mucosa, tongue, lips, nasopharynx, oropharynx, nasal and vaginal mucosa, the front zone of the eye globe and the precancerous and cancerous lesions (local chemotherapeutics, radiosensitizers, photosensitizers, cryogenic agents, chemosurgery agents, substances such as the ionized argon used in the argon plasma technique, liquids used for the thermochemotherapy and thermochemosurgery, liquid local hemostatics, antimicrobial drugs for treating the persistence infections, antimycotic drugs, some drugs and dyes used for the diagnosis and, liquid, gas or pomade substances that will accelerate the tissue healing).
In Industry (For the window cleaning):
It can be used in the window cleaning of high-rise buildings. Window cleaning can be done by water, detergent, moist hot air sent for cleaning and hot dry air sent fro drying into the tent room ( 1 ) of devices with the ventouse edges suitable for the peripheral shapes of windows.
Present Common Condition of Technique
Surface disinfection in medicine
There is not any local application in some cancers that are in the usage area of Surface Disinfection Device, except for the intratumoral injection. Even though the lesion is on an easy accessible surface, since there is not any areal drug application device that well limits the drug administered, the systemic high dosing applications are carried out in order to attain the desired concentration of drug in the lesion area. While the systemic chemotherapy causes the significant reversible and irreversible adverse effects, high dose of antibiotherapy can cause superinfections. Increase in the amount of drugs used increases the destruction in the organs in which the drugs are decomposed and discarded.
Pomades are relatively effectively used only for the skin and, the liquid drugs are used in a staining way. In the intraoral application, mobility of the saliva and tissues inhibits the drug to stay in the application area for a long time.
The photosensitizers used for the cancer treatment are administered systemically and require 1-5 days to become effective in the body (delay in the treatment) and, their photosensitizing adverse effects for the patients lasts for weeks. The patients exposed to the light can have critical problems.
Thermotherapy and thermochemotherapy agents cannot be applied, since the liquid spread cannot be limited to single area because of the heat.
The leucoplasias and some oral lichen planus are considered as the precancerous lesions by some specialists and nonselective cryotherapies are performed.
Ring ventouse system is used for fixing the eyeball in the eye surgery (Hessburg- Barron Vacuum Trephine). However, there is not any adherent membrane that
makes the system a closed tent on the upper part of this ring ventouse. It is hypaethral and the surgical operations are made from this open area. By this device, it is impossible to keep the drugs fixed in that area. But, by the Surface Disinfection Device, the upper part of peripheral ventouse, including the area in the center of ventouse ( 6 ), is covered by an elastic membrane. Thus, a closed tent room ( 1 ) is formed. When a Surface Disinfection Device is placed on a tissue ( 3 ) and the air in the peripheral ventouse ( 2 ) is vacuumed, the device firmly adheres to the lower tissues and does not drain the drugs and chemical substances sent into the tent via the disinfection duct ( 20 ), unless it is desired.
The invention named medicinal component delivery system moves the skin upward-downward significantly in the medicine application zone with the discharge pump and ultrasonic module. This causes burnt skin, infected skin and an unacceptable case for medicine application on the front zone of the eye globe. Our device does not apply positive or negative pressure on and does not disturb the medicine application zone in any manner.
In the said device, the medicine application zone is only the sub-part of the structure #31. In our device, the medicine application zone is the entire surface in the inner tent area ( 3 ).
Such kind of an ultrasonic module is not required to apply many medicines. This module increase the price and weight of the system. As the weight increases, it will be required to increase the negative pressure needed to keep the system attached to the tissue, which means edema, hemorrhage and hematome on the tissue.
In Industry (For the window cleaning)
For the cleaning of multi-storey buildings' windows that are difficult-to-reach, the cleaning is done directly by hand by the people on the structures suspended from top of the building.
Window cleaning is sometimes tried to be done by robots adhered to and fixed on the windows by ventouses. However, pouring of the detergents is unavoidable in
all these systems. Detergents falling down from 50 m. will affect the objects and people which are 10 m. around of the building and cause the environmental pollution.
Advantages of Surface Disinfection Device
90 In Medicine:
1. Drugs are applied only to the desired area and, do not spill to the surrounding tissues.
2. The device ensures that the desired drug concentration is attained and maintained in the desired area. This ensures an increase in the success of
95 treatment and a shorter treatment time. It is impossible to attain this concentration in the application of systemic chemotherapy and systemic antibiotherapy.
3. The device allows very little amounts of drug to pass to the systemic circulation by passing through the skin and mucosa in the application area.
100 This provides:
• Less systemic adverse effects (it is very critical for chemotherapies.).
• No superinfections in antibiotherapy
• Less strain and destruction in the liver and kidneys.
• Since the amount of drug that will pass to the systemic circulation is 105 very little, even if the drug is substantially toxic, it can be used in safe in such cases as the cancer treatment.
4. By local using ofphotosensitizer drugs used in the cancer treatment:
While the effect of drug posteriorly starts in systemic use of the drug, this period significantly shortens by direct application of the drug on the mass 110 • areally.
• Photosensitization that is seen in the systemic use and lasts for weeks is not seen, after the areal applications by the Surface Disinfection device,
since the relevant area can easily be protected against the light, because of the fact that whole body surface is not photosensitized.
115 5. The radiosensitizers that areally applied become effective further and in a shorter time.
6. Since the application of Surface Disinfection Device is easy and safe, prophylactic drugs can be applied in the precancerous lesions.
7. Areal corticosteroid treatments can be performed in the pemphigus and 120 aphtha.
8. It is not possible to areally administer the drugs of cryogenic and thermotherapy - thermochemosurgery treatments by specifically limiting through the present common methods in the usage areas of Surface Disinfection Device. The Surface Disinfection Device ensures this easily by
125 confining the drugs into the tent room ( 1 ).
9. The administered drug can be kept in the area as long as desired. This means that the drug efficiency will continue as long as desired. For example, some microorganisms should be kept under influence by the antimicrobial drugs for dying. This is ensured in the systemic applications by frequently, long
130 and dense drug administering. In the areal application, for instance, if the microorganism dies by an X-density drug as a result of interaction of Y minutes, a definite result would be obtained by single application at the end of Y minutes, since the X-density can be attained by an areal application and it will be easy to keep the drug there for Y minutes.
135 lO.The area may be deoxidized in order to kill the aerobes. To do this, the air in the tent room ( 1 ) is vacuumed and instead, substances in the aerosol form that will kill the microorganisms and will not harm the underlying tissue can be given.
11. The microorganisms can be killed by making the pH of area
140 inconvenient for the microorganisms by the drugs to be administrated.
In Industry (For the window cleaning):
■1. The detergents sprayed to the tent room ( 1 ) for the purpose of window cleaning cannot scatter around and thus, will not pollute the environment. 145 2. Since the detergent granules will not splash to the heads of people, it is not necessary to prevent the building's entrance and exit.
3. If the detergent does not become disposable after the cleaning of one window, the remaining detergent can be retrieved from the disinfection duct ( 20 ) and used in the cleaning of next window. 150
Formal and structural properties of the system In Medicine
The peripheral ventouse ( 2 ) is designed as factory made in various geometric figures and various diameters according to the application area.
155 In the labial applications, the peripheral ventouse system is U-shaped and able, to grasp the lips.
The outer edges of those that will be used in the buccal mucosa should be appropriate for the area's anatomy. It should be designed in different circumferential lengths according to the age. Again, it should be designed as 160 factory made in different dimensions by considering that some people may have bigger or smaller mouths.
Whole system should be made of transparent material in order to watch the incidents in it, providing that the drug to be administered is not likely to be affected by light.
165 In the applications of thermochemotherapy and thermochemosurgery, whole system is made of heat resistant materials.
The height of peripheral ventouse ( 5 ) should be as short as possible. Thus, the required amount of drug decreases and then, the cost and negative pressure that is enough to overcome the severity of drug are also reduced. The height of
170 peripheral ventouse ( 5 ) should be high enough not to cause the tent part will
touch the application surface. Non-touching of tent surface to the application surface should not be ensured by drug administering with pressure. Otherwise, it will be required to create more negative pressure within the peripheral ventouse system ( 2 ) in order to overcome such pressure.
175 The peripheral ventouse 's lips ( 7 ) adhering to the tissue shall be elastic so as not to irritate the tissue and so as can adapt to the surrounding anatomic structure.
In long-term applications, the devices of which peripheral ventouse system's width ( 15 ) is wide should be preferred.
180 In Industry
Whole system shall be made of elastic and transparent materials that will not be affected by the chemical substances to be used in the application and harm the structure of such substances. Its edge's form should match up with the form of window's edge.
185 There are disinfection duct ( 20 ), vacuum duct ( 17 ), and air bleed duct ( 18 ) in the ducts system ( 4 ).
Functions of Parts in System:
190 a. Tent room ( 1 ) : It is the application area of the drug of which upper part is surrounded by an elastic membrane forming the ceiling ( 6 ) of tent room, lower part is surrounded by the tissue and edges are surrounded by the inner wall ( 14 ) of ventouse. ( Figure 1 ) b. Peripheral ventouse ( 2 ) : Vacuuming in this area sticks the Surface 195 Disinfection Device to the tissue. As a result of this adherence, the drugs administered to the tent room cannot leak out. ( Figure 1 ) c. Application area ( 3 ): Floor section of the tent room. ( Figure 1 ) d. Ducts system ( 4 ): It is the system including the vacuum duct ( 17 ), air bleed duct ( 18 ), disinfection duct ( 20 ), and observation duct
200 ( 19 ). ( Figure 1 )
e. Height of the peripheral ventouse ( 5 ) : It is the section between the contact area of ventouse to the tissue and the adherence area of ceiling ( 6 ) of tent room to the ventouse. The height that is as lower as possible to meet the amount of drug intended to be administered 205 should be preferred. This will prevent the severity of system and therefore, unnecessary high vacuuming. This means less edema. ( Figure 1 ) f. Ceiling of tent room ( 6 ) : Thin, elastic structure forming the ceiling of system. ( Figure 1 )
210 g. Adherence lips of ventouse ( 7 ) : Ventouse' s area adhering to the tissue during vacuuming. ( Figure 1 ) h. Outlet of Vacuum duct ( 8 ) : It is located on the outer edge of ducts system ( 16 ), and connects to the vacuum device through a connector. ( Figure 2 )
215 i. Outlet of air bleed duct ( 9 ): It is located on the outer edge of ducts system ( 16 ). ( Figure 2 ) j. Outlet of disinfection duct ( 10 ): It is located on the outer edge of ducts system ( 16 ) . ( Figure 2 ) k. Outlet of observation duct ( 11 ): It is located on the outer edge of
220 ducts system ( 16 ). This place is able to be connected to the observation instrument through a connector. It does not have to be in the devices to be used in the applications that the incidents inside can easily be watched. ( Figure 2 )
1. Inlet of air bleed duct ( 12 ) : It is located in the middle, on the
225 ceiling of tent room ( 6 ). It is the edge of air bleed duct ( 18 ) that opens into the tent room ( 1 ). Its location varies according to the application area by calculating where the air in the tent will be accumulated according to the gravity. This hole is in the center of tent where the base of Surface Disinfection Device will be located in
230 parallel with the ground. In the applications of buccal mucosa, it is on
the upper part of tent room. Of course, its duct will have a different course, accordingly. Its function is to bleed the air in the tent room ( 1 ) during the drug administering and ensure the area to be fully filled with the drug. ( Figure 2 )
235 m. Inlet of vacuum duct ( 13 ) : It is in the middle of ceiling ( 15 ) of peripheral ventouse ( 2 ). It is the inlet port of vacuum duct ( 17 ) (
Figure 6 ). Vacuuming can be performed from 1, 2, 3 or 4 points according to the size of ventouse system. n. Inner wall of peripheral ventouse ( 14 ) : It is the inner wall ( 14 ) of
240 peripheral ventouse ( 2 ). The device ends here( 21 ) in the devices with an observation instrument in an area of this wall close to the tent( 6 ), in the inner part fronting on the tent room( 1 ). Again, there is the inlet of disinfection duct ( 22 ) in the part of this wall close to the ground. The observation duct ( 19 ) and disinfection duct ( 20 )
245 . navigate in this wall after going out of the ducts system (4). ( Figure >
1) o. Width - ceiling of peripheral ventouse system ( 15 ) : It is the distance between the vertical walls constituting the peripheral ventouse. While it increases, the vacuum-related edema decreases. 250 The inlet ( 13 ) of vacuum duct ( 17 ) exist on its ceiling, in the middle. ( Figure 1 ) p. Outer edge of ducts system ( 16 ) : It is the out-of-body edge of elastic structure that connects the system to the out of body and includes the ducts. Here exists the outlet of vacuum duct ( 8 ), outlet 255 of disinfection duct ( 11 ), outlet of air bleed duct ( 9 ) and beginning of observation system( 21 ) in which the observation instruments are located. ( Figure 1 ) q. Vacuum Duct ( 17 ) : It is the duct vacuuming the air in the peripheral ventouse ( 2 ) ( Figure 6 ). It is located within the ducts system ( 4 ). 260 Vacuuming can be performed from 1, 2, 3 or 4 points according to the
size of ventouse system. In this case, the branches from the vacuum duct or additional vacuum ducts are constituted. r. Air bleed duct ( 18 ) : It is the duct that ensures the air in the tent room to be bled to the external environment. Thus, inside of the room 265 is filled with the drug. It prevents the positive pressure generation in the tent room ( 1 ) during the drug administering. This duct also ensures that the drug is activated by aerating the drug, where the drug in the tent room ( 1 ) is desired to be activated from time to time.
Whenever necessary, it can be used as a backup drug drainage duct by 270 connecting to an aspirator. It is located within the ducts system ( 4 ).
(Figure 3) s. Disinfection duct ( 20 ) : It is the duct that carries the drug from outside to underneath of the tent during the drug administering and from inside of the tent to outside during the drainage. It is located 275 within the ducts system ( 4 ). ( Figure 5 ) t. Observation instrument duct ( 19 ) : It includes the systems for observing the tent room ( 1 ). It is located within the ducts system
( 4 ). ( Figure 4 ) u. Inlet of Disinfection duct ( 22 ) : It is the outlet port of drug 280 administering and drainage duct opening into the tent room (1). It is on the side of inner cylinder ( 14 ) constituting the peripheral ventouse, fronting on the tent room ( 1 ) and in an area of tent close to the application area ( 3 ). ( Figure 5 ) v. Beginning of observation system ( 21 ) : It is located over the inner 285 . wall ( 14 ) of peripheral ventouse and in an area close to the tent ( 6 ).
The fiber optic systems that can observe the application area can be located close to the upper part of ventouse' s wall fronting on the tent area or in the middle of tent. ( Figure 4 )
290
APPLICATION OF SURFACE DISINFECTION DEVICE
Selection of application device: 295 In Medicine
The device of which shape is optimal for the area of lesion is selected. If the drug is a hot liquid, the physical structure of device should be suitable for that. If the drug is likely to be affected by light, a device that is light-proof is used or, during the drug administering, the tent is covered by a light-proof cloth.
300 In Industry (For the window cleaning)
A device that will match up with the surface of window is selected. It is made of transparent materials. Since the ventouse edges will constitute the frame, they are made of thicker elastic materials such as the rigid plastic. Application in Medicine
305 • Before administering the drug, the patient is located so as that the drug will reach the target tissue in an easiest way according to the gravity. This will be different for the liquids and gases.
• The Surface Disinfection Device is located in the lesion area. While it is kept in a condition slightly pressed through a finger or a tool, the vacuum
310 device is started. A negative pressure is generated in the peripheral ventouse area.
• When it is understood that the Surface Disinfection Device is fully adhered to the tissue, the drug is started to be administered by an injector from the outlet of disinfection duct ( 11 ). In the meantime, the outlet of air bleed duct
315 ( 9 ) is open. Once the drug starts to come from the outlet of air bleed duct
( 9 ), the drug administering is stopped. The mouth of outlet of air bleed duct ( 9 ) is closed. If the application plane is in parallel with the ground and the inside of net is clearly visible, when the sufficient drug is administered, the drug administering can be terminated without waiting for the drug coming
320 from the outlet of air bleed duct ( 9 ).
• The tent room ( 1 ) is not fully filled where the liquid drug is required to be activated from time to time by aerating.
Drug Drainage
325 • The inlet of disinfection duct ( 11 ) and the mouth of outlet of air bleed duct
( 9 ) are opened. The drug leaks out of the device. This drainage may be performed by retracting an injector piston inserted to the inlet of disinfection duct ( 11 ).
• For the risky drugs, a full drainage is achieved by inserting a vacuum device 330 to the inlet of disinfection duct ( 11 ).
Termination of application
After the drug is drained, the negative pressure in the peripheral ventouse ( 2 ) is relieved by opening the outlet of vacuum duct ( 8 ).
Description of Figures
335 Figure 1 - General view of device
Figure 2 - Edge of ducts system to be connected to a connector
Figure 3 - Air bleed duct and inlet of air bleed duct
Figure 4 - Observation duct and beginning of observation system
Figure 5 - Disinfection duct and entrance of disinfection duct
340 Figure 6 - Vacuum duct and entrance of vacuum duct
Names of Parts Enumerated in the Figures
I- Tent room
2 - Peripheral ventouse
3 - Application area
4 - Ducts system 5 - Height of peripheral ventouse
6 - Ceiling of tent room
7 - Adherence lips of peripheral ventouse to the tissue
8 - Outlet of vacuum duct
9 - Outlet of air bleed duct 10- Outlet of observation duct
I I- Outlet of disinfection duct
12- Inlet of air bleed duct
13- Inlet of vacuum duct
14- Inner wall of peripheral ventouse 15- Width - ceiling of peripheral ventouse system
16- Outer edge of ducts system
17- Vacuum duct
18- Air bleed duct
19- Observation duct 20- Disinfection duct
21- Beginning of observation system
22- Inlet of disinfection duct
Claims
1. Whereas the Surface Disinfection Device; it is characterized by its property of being composed of a tent room ( 1 ) that is the area in which the drug is applied and confined, a peripheral ventouse ( 2 ) that fixes the devices on the application area by negative pressure and prevents the leakage of drugs out of
380 the tent room, a disinfection duct ( 20 ) that sends drug to the tent room ( 1 ) and drains the drug in the tent room(l), an air bleed duct ( 18 ) that will ensure that the air in the tent room ( 1 ) will be bled during the drug administering, an observation duct ( 19 ) that includes the systems by which the progress in the tent room can be observed, and a vacuum duct ( 17 ) that
385 ' will bleed the air in the peripheral ventouse ( 2 ).
2. Whereas the disinfection duct ( 20 ), air bleed duct ( 18 ), observation duct
( 19 ) and vacuum duct mentioned in Demand 1, they are characterized by their property of being located within the ducts system ( 4 ).
3. Whereas the tent room ( 1 ) mentioned in Demand 1, it is characterized by its 390 property of being limited to the ceiling ( 6 ) of tent room and inner wall ( 14 ) of- peripheral ventouse.
4. Whereas the ceiling ( 6 ) of tent room mentioned in Demand 1, it is characterized by its property of containing the inlet of air bleed duct ( 12 ) on its side fronting on the tent room ( 1 ).
395 5. Whereas the peripheral ventouse ( 2 ) mentioned in Demand 1, it is characterized by its property of being limited to the inner wall ( 14 ) of peripheral ventouse, width - ceiling ( 15 ) of peripheral ventouse system and peripheral ventouse' s adherence lips ( 7 ) to the tissue.
6. Whereas the peripheral ventouse ( 2 ) mentioned in Demand 1, it is 400 characterized by its property of having the inlet of vacuum duct ( 13 ) on the width - ceiling ( 15 ) of peripheral ventouse system.
7. Whereas the inner wall ( 14 ) of peripheral ventouse ( 2 ) mentioned in Demand 1, it is characterized by its property of containing the beginning of observation system ( 21 ) close to its upper bound and inlet of disinfection duct ( 22 ) close 405 to its lower edge.
8. Whereas the peripheral ventouse ( 2 ) mentioned in Demand 1, it is • characterized by its periphery's property of being in different geometric figures in accordance with the anatomies of application areas.
9. Whereas the Surface Disinfection Device; it is characterized by its shape's 410 property of being that will grasp the application area, like the device to be used in the labial applications is U-shaped.
415
420
425
430
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2008/08380 | 2008-11-06 | ||
TR2008/08380A TR200808380A2 (en) | 2008-11-06 | 2008-11-06 | Surface spraying device |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010053463A1 true WO2010053463A1 (en) | 2010-05-14 |
Family
ID=41665302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2009/000134 WO2010053463A1 (en) | 2008-11-06 | 2009-11-05 | Surface disinfection device |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR200808380A2 (en) |
WO (1) | WO2010053463A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012007698A1 (en) * | 2010-07-13 | 2012-01-19 | Universite Joseph Fourier | Device for controlling a blood flow produced in a hemorrhagic area |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3786801A (en) * | 1969-02-24 | 1974-01-22 | Diagnostic Inc | Method and apparatus for aiding in the detection of breast cancer |
WO1998038944A1 (en) * | 1997-03-05 | 1998-09-11 | Board Of Regents, The University Of Texas System | Self-sealed irrigation system |
US5941859A (en) * | 1997-03-17 | 1999-08-24 | Lerman; Benjamin S. | Wound irrigation shield with fluid scavenging |
US20050165346A1 (en) * | 2002-08-22 | 2005-07-28 | Neilson Geoffrey J. | Double-sided surgical irrigator |
WO2006012992A1 (en) * | 2004-07-29 | 2006-02-09 | Heinrich Peirlberger | Rinsing/suction adapter |
-
2008
- 2008-11-06 TR TR2008/08380A patent/TR200808380A2/en unknown
-
2009
- 2009-11-05 WO PCT/TR2009/000134 patent/WO2010053463A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3786801A (en) * | 1969-02-24 | 1974-01-22 | Diagnostic Inc | Method and apparatus for aiding in the detection of breast cancer |
WO1998038944A1 (en) * | 1997-03-05 | 1998-09-11 | Board Of Regents, The University Of Texas System | Self-sealed irrigation system |
US5941859A (en) * | 1997-03-17 | 1999-08-24 | Lerman; Benjamin S. | Wound irrigation shield with fluid scavenging |
US20050165346A1 (en) * | 2002-08-22 | 2005-07-28 | Neilson Geoffrey J. | Double-sided surgical irrigator |
WO2006012992A1 (en) * | 2004-07-29 | 2006-02-09 | Heinrich Peirlberger | Rinsing/suction adapter |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012007698A1 (en) * | 2010-07-13 | 2012-01-19 | Universite Joseph Fourier | Device for controlling a blood flow produced in a hemorrhagic area |
FR2962639A1 (en) * | 2010-07-13 | 2012-01-20 | Univ Joseph Fourier | DEVICE FOR CONTROLLING A BLOOD FLOW EXECUTING IN A HAEMORRHAGIC AREA |
CN103140247A (en) * | 2010-07-13 | 2013-06-05 | 约瑟夫·傅立叶大学 | Device for controlling a blood flow produced in a hemorrhagic area |
US9919083B2 (en) | 2010-07-13 | 2018-03-20 | Universite Joseph Fourier | Device for controlling a blood flow produced in a hemorrhagic area |
US11083826B2 (en) | 2010-07-13 | 2021-08-10 | Hemosquid | Device for controlling a blood flow produced in a hemorrhagic area |
Also Published As
Publication number | Publication date |
---|---|
TR200808380A2 (en) | 2009-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2807800C (en) | Wound treatment and containment arrangement | |
KR101373506B1 (en) | Photodisinfection delivery devices and Methods | |
McGuinness et al. | Vacuum-assisted closure of a complex pilonidal sinus | |
Thomas et al. | Comparative evaluation of canal isthmus debridement efficacy of modified EndoVac technique with different irrigation systems | |
CN102019028B (en) | In-vivo dry powder conveying device and implementation method thereof | |
US20100160838A1 (en) | Two step mammalian biofilm treatment processes and systems | |
US20100168823A1 (en) | Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation | |
US20050107853A1 (en) | Control of rhinosinusitis-related, and other microorganisms in the sino-nasal tract | |
JP2023029490A (en) | Device to prevent premature birth | |
CN105163759A (en) | Biophotonic materials and uses thereof | |
AU2014338565B2 (en) | Positionable delivery device and method | |
TW200407178A (en) | Methods, devices and formulations for targeted endobronchial therapy | |
Wisithphrom et al. | Interactions between cavity preparation and restoration events and their effects on pulp vitality. | |
CN106512187A (en) | Respiratory internal medicine drug sprayer | |
WO2010053463A1 (en) | Surface disinfection device | |
CN105664312A (en) | Atomization inhalation therapeutic apparatus | |
CN1753656B (en) | Bioadhesive liquid composition which is substantially free of water | |
CN101081318A (en) | Aspirator, soiling solution bottle and metal flexible pipe lamp, delivery tube nozzle and feeder of the aspirator | |
Bonsor et al. | Current clinical applications of photo-activated disinfection in restorative dentistry | |
JP2021524333A (en) | Treatment methods and equipment using systems to control the flow of gaseous media | |
CN109999239A (en) | A kind of medically novel drainage device | |
Platt et al. | The effectiveness of compomer as a root-end filling: a clinical investigation | |
CN207545613U (en) | Inflatable medical anal canal | |
CN213098024U (en) | Infectious disease sampling device | |
KR20210064030A (en) | Dual body drug Iinjection device for mucus removal function of the sinuses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09796491 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09796491 Country of ref document: EP Kind code of ref document: A1 |